Bacitracin (bacitracin)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Bacitracin is a polypeptide antibiotic.
USES: This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections.
It will not work for other types of eye infections. Using any antibiotic when it is not needed can cause it to not work for future infections.
Generic name: bacitracin
Pronunciation: (BAS-i-TRAY-sin)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Bacitracin
Indications
The following indications are listed for Bacitracin:
- Superficial Ocular Infection
Also known as: Superficial Ophthalmic Infection.
Dosing
Dosage of bacitracin or bacitracin zinc is expressed in terms of the base.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
Animal reproduction studies have not been performed with bacitracin. It is not known whether ophthalmic preparations containing bacitracin or bacitracin zinc can cause fetal harm when administered to pregnant women.
Fixed-combination ophthalmic preparations containing bacitracin zinc and polymyxin B sulfate with or without neomycin sulfate should be used during pregnancy only if clearly needed.
Fixed-combination ophthalmic preparations containing bacitracin zinc, neomycin sulfate, polymyxin B sulfate, and a corticosteroid (i.e., hydrocortisone, hydrocortisone acetate) should be used during pregnancy only if potential benefits justify potential risks to the fetus.
It is not know whether bacitracin is distributed into milk.
Bacitracin and fixed-combination ophthalmic preparations containing bacitracin zinc and polymyxin B sulfate with or without neomycin sulfate should be used with caution in nursing women.
The manufacturers of fixed-combination ophthalmic preparations containing bacitracin zinc, neomycin sulfate, polymyxin B sulfate, and a corticosteroid (i.e., hydrocortisone, hydrocortisone acetate) state that a decision should be made whether to discontinue nursing or the ophthalmic preparation, taking into account the importance of the drug to the woman.
Some experts consider topical bacitracin compatible with nursing.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.